European Accreditation is granted by the EACCME in order to allow participants who attend the above-mentioned activity to validate their credits in their own country.
- TOXINS 2015: Basic Science and Clinical Aspects of Botulinum and Other Neurotoxins is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
- The Toxins 2015: Basic Science and Clinical Aspects of Botulinum and Other Neurotoxins’ is designated for a maximum of (or ‘for up to’) 15 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity
- Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
- Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Mount Sinai Beth Israel and The International Neurotoxin Association (INA). Mount Sinai Health System Hospitals: Mount Sinai Beth Israel, Mount Sinai St. Luke’s and Mount Sinai Roosevelt, are accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Mount Sinai Beth Israel designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
POLICY ON FACULTY AND PROVIDER DISCLOSURE
It is the policy of Mount Sinai Health System Hospitals: Mount Sinai Beth Israel, Mount Sinai St. Luke’s and Mount Sinai Roosevelt, that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity and have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
Jointly sponsored by Mount Sinai Beth Israel and the International Neurotoxin Association